Jenny C Hoffmann, MD
Pathology · Denver
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 13 years
- Graduated 2013
Offices
1 location · Elevated Pathology PLLC · 6 clinicians in this group
Looking this up.
Hospitals listed: Adventhealth Avista · Adventhealth Castle Rock · Adventhealth Littleton · Adventhealth Parker · Adventhealth Porter. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hoffmann’s office at (303) 778-1955 to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington MD.MD.60943137Physician And Surgeon License · since 2019 · expires 2022-03-05ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventhealth AvistaLouisville, COAcute Care Hospital · Voluntary non-profit - Church · No emergency department · Birthing-friendlyPart of AdventHealth, which runs 42 hospitals in 9 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Adventhealth Castle RockCastle Rock, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of AdventHealth, which runs 42 hospitals in 9 statesPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.135, Oct 2024 – Sep 2025
- Adventhealth LittletonLittleton, COAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of AdventHealth, which runs 42 hospitals in 9 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.292, Oct 2024 – Sep 2025
- Adventhealth ParkerParker, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of AdventHealth, which runs 42 hospitals in 9 statesPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.496, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0, Oct 2024 – Sep 2025
- Adventhealth PorterDenver, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of AdventHealth, which runs 42 hospitals in 9 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.494, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventhealth Avista
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 2 better, 3 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.05) · 285 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.52 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 13.2 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.8 · 46 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 471 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 868 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.7 to 6.44) · 438 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 340 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.43 (0.78 to 4.09) · 417 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.12 (1.81 to 18.42) · 340 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.31 (0.37 to 8.26) · 340 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.49 (0 to 1.68) · 468 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.212 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.792 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 41 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -38.2 · 34 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -23.9 · 52 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.5 to 7.2) · 171 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.7 (10.6 to 17.7) · 171 cases | No different | Jan 2024 – Dec 2024 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.5 to 16.8) · 675 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 251 cases | No different | Jan 2024 – Dec 2024 |
What patients said (349 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 65% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Adventhealth Castle Rock
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.135 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0 to 2.05) · 269 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.49 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,114 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,677 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.13 to 0.55) · 1,644 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.37 (0.95 to 5.79) · 387 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.18 (0.5 to 3.86) · 345 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.16 (0.92 to 19.41) · 151 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.86 (0.67 to 9.04) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.06 (0.55 to 3.58) · 112 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.46) · 1,154 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 43 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 54 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.5 · 110 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -19.2 · 140 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 182 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 48 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9.3 to 16.2) · 639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 324 cases | No different | Jan 2024 – Dec 2024 |
What patients said (533 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Adventhealth Littleton
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 1 better, 7 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.292 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.13 to 2.14) · 659 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.72 to 1.45) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.64 (115.59 to 217.69) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.9 · 53 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 293 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 308 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 2,575 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.01 to 0.43) · 4,124 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,030 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.48 to 5.73) · 1,035 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.89 (0.26 to 3.51) · 360 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.25 (1.68 to 4.81) · 973 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.62 (5.96 to 21.28) · 371 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.77 (0.96 to 8.58) · 350 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 193 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.34) · 3,176 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 49 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.617 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.01 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.425 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 143 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 474 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 9.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.3 · 329 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.6 · 323 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 477 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 50 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 99 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.6 to 16.8) · 406 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 340 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,114 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Adventhealth Parker
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 3 better, 7 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.496 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.9) · 644 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.65 to 1.41) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 201.36 (143.28 to 259.43) · 49 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 11.3 · 61 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.3 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.2 · 176 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.6 · 172 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 2,118 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,441 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,411 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.18 (1.99 to 6.37) · 868 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.29) · 348 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (0.39 to 3.6) · 794 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 15.69) · 357 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.5 (3.53 to 11.46) · 351 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.14) · 258 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.44) · 2,659 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 49 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.91 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.798 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 2.001 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 105 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 297 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -46.4 · 72 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -6.2 · 193 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -17.5 · 208 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 323 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.8 to 17) · 887 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 353 cases | No different | Jan 2024 – Dec 2024 |
What patients said (854 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Adventhealth Porter
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.494 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.12 to 2.11) · 829 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.57 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 132.86 (77.03 to 188.69) · 58 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.2 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 147 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 101 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.1 · 50 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 1,833 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 2,802 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.36 (0.15 to 0.56) · 3,003 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.85 (1.75 to 5.95) · 1,103 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.79 (0.21 to 3.38) · 623 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.99 (1.49 to 4.48) · 980 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.18 (2.91 to 15.44) · 680 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.9 (1.55 to 8.24) · 656 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.96 (0.48 to 3.43) · 424 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.14) · 2,108 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 68 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.243 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.459 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.011 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.354 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 56 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -34.3 · 175 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.3 · 107 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 194 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 88 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.4 to 17.2) · 290 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 673 cases | No different | Jan 2024 – Dec 2024 |
What patients said (740 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 56% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$70,847
Medicare paid this office $70,847 for 617 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Pathology examination of tissue using a microscope, intermediate complexity | 368 | $18,260 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 77 | $11,576 | $64 |
| Special stained specimen slides to examine tissue, each additional procedure | 96 | $10,832 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 123 | $5,733 | $27 |
| Microscopic genetic analysis of tumor, manual | 39 | $3,345 | $32 |
See all 24 services
| Pathology examination of tissue using a microscope, intermediate complexity | 368 | $18,260 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 77 | $11,576 | $64 |
| Special stained specimen slides to examine tissue, each additional procedure | 96 | $10,832 | $22 |
| Special stained specimen slides to examine tissue, initial procedure | 123 | $5,733 | $27 |
| Microscopic genetic analysis of tumor, manual | 39 | $3,345 | $32 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 33 | $2,818 | $64 |
| Pathology examination of specimen during surgery, first tissue block | 24 | $2,308 | $48 |
| Evaluation of fine needle aspirate with interpretation and report | 28 | $2,168 | $54 |
| Blood smear interpretation by physician with written report | 91 | $2,146 | $19 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 26 | $1,308 | $48 |
| Pathology cytologic examination of specimen during surgery, initial site | 25 | $1,194 | $48 |
| Evaluation of fine needle aspirate | 28 | $1,095 | $27 |
| Genetic sequencing localization, initial procedure | 28 | $1,013 | $33 |
| Bone marrow, smear interpretation | 23 | $864 | $38 |
| Pathology examination of tissue using a microscope, moderately low complexity | 73 | $719 | $9 |
| Genetic sequencing localization, each additional procedure | 23 | $695 | $26 |
| Preparation of tissue for examination by removing any calcium present | 48 | $645 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 15 | $600 | $21 |
| Special stained specimen slides to examine tissue including interpretation and report | 24 | $580 | $9 |
| Cell examination of specimen, selective cellular enhancement technique | 25 | $579 | $21 |
| Pap test, evaluation of fine needle aspirate, immediate, each additional evaluation episode | 11 | $236 | $17 |
| Cell examination of specimen, concentration technique | 11 | $226 | $17 |
| Crystal identification from tissue or body fluid | 13 | $181 | $14 |
| Pathology examination of tissue using a microscope | 12 | $69 | $5 |
Who their Medicare patients are
617 Original Medicare patients in 2024. Average age 73 · Under 65 6% · 85 and older 7% · Women 57% · Also on Medicaid 12% · Health risk score 1.50. At or below the middle of the specialty; the typical pathology clinician is at 1.55.
Conditions among them: High blood pressure 72% · Coronary heart disease 28% · Diabetes 27% · Chronic kidney disease 26% · Cancer 26% · Depression 25% · COPD 20% · Heart failure 19% · Atrial fibrillation 17% · Stroke 11% · Dementia 9%.
The office billed $457,287, Medicare allowed $89,776 and paid $70,847; for 2,440 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 617 | 2,440 | 73 | 1.50 | $457,287 | $70,847 |
| 2023 | 451 | 1,715 | 74 | 1.71 | $310,663 | $51,363 |
| 2022 | 522 | 1,770 | 73 | 1.55 | $326,791 | $53,213 |
| 2021 | 893 | 3,903 | 73 | 1.48 | $352,960 | $124,491 |
| 2020 | 609 | 3,047 | 73 | 1.57 | $269,965 | $98,417 |
| 2019 | 305 | 1,699 | 73 | 1.64 | $144,921 | $53,672 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 17 services
| Special stained specimen slides to examine tissue, each additional procedure | 81 | $9,050 | $22 |
| Pathology examination of tissue using a microscope, intermediate complexity | 174 | $7,963 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 53 | $7,159 | $64 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 81 | $5,653 | $65 |
| Special stained specimen slides to examine tissue, initial procedure | 118 | $4,600 | $27 |
| Microscopic genetic analysis of tumor, manual | 32 | $3,619 | $33 |
| Blood smear interpretation by physician with written report | 122 | $2,828 | $18 |
| Pathology examination of specimen during surgery, first tissue block | 19 | $1,849 | $49 |
| Genetic sequencing localization, initial procedure | 28 | $1,180 | $34 |
| Flow cytometry technique for dna or cell analysis, 9 to 15 markers | 19 | $930 | $49 |
| Pathology cytologic examination of specimen during surgery, initial site | 18 | $924 | $49 |
| Bone marrow, smear interpretation | 22 | $824 | $36 |
| Genetic sequencing localization, each additional procedure | 19 | $533 | $27 |
| Preparation of tissue for examination by removing any calcium present | 48 | $525 | $9 |
| Pathology examination of tissue using a microscope, moderately low complexity | 45 | $497 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $421 | $20 |
| Special stained specimen slides to examine tissue including interpretation and report | 22 | $305 | $9 |
2022: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 235 | $11,757 | $29 |
| Pathology examination of tissue using a microscope, moderately high complexity | 69 | $8,925 | $66 |
| Special stained specimen slides to examine tissue, each additional procedure | 74 | $7,264 | $22 |
| Microscopic genetic analysis of tumor, manual | 51 | $4,404 | $34 |
| Special stained specimen slides to examine tissue, initial procedure | 108 | $3,816 | $28 |
| Blood smear interpretation by physician with written report | 133 | $3,129 | $20 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 41 | $3,120 | $66 |
| Genetic sequencing localization, initial procedure | 32 | $1,356 | $34 |
| Pathology examination of specimen during surgery, first tissue block | 17 | $1,057 | $48 |
| Pathology cytologic examination of specimen during surgery, initial site | 17 | $854 | $50 |
| Preparation of tissue for examination by removing any calcium present | 56 | $729 | $10 |
| Bone marrow, smear interpretation | 17 | $700 | $39 |
| Genetic sequencing localization, each additional procedure | 21 | $617 | $27 |
| Pathology examination of tissue using a microscope, moderately low complexity | 55 | $574 | $9 |
| Blood bank physician services for cross match and/or evaluation and written report | 12 | $524 | $40 |
| Special stained specimen slides to examine tissue including interpretation and report | 19 | $331 | $10 |
| Crystal identification from tissue or body fluid | 18 | $282 | $15 |
2021: 38 services
| Special stained specimen slides to examine tissue, each additional procedure | 152 | $16,170 | $22 |
| Pathology examination of tissue using a microscope, intermediate complexity | 332 | $16,025 | $28 |
| Pathology examination of tissue using a microscope, moderately high complexity | 118 | $10,529 | $63 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 44 | $7,574 | $52 |
| Special stained specimen slides to examine tissue, initial procedure | 189 | $6,435 | $27 |
| Pathology examination of tissue using a microscope, intermediate complexity | 151 | $6,229 | $27 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 73 | $5,196 | $64 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 73 | $5,073 | $66 |
| Pathology cytologic examination of specimen during surgery, initial site | 79 | $4,404 | $47 |
| Microscopic genetic analysis of tumor, manual | 74 | $4,404 | $33 |
| Special stained specimen slides to examine tissue, each additional procedure | 35 | $3,409 | $25 |
| Cell examination of specimen, selective cellular enhancement technique | 102 | $3,255 | $21 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 14 | $2,791 | $66 |
| Pathology examination of tissue using a microscope, high complexity | 22 | $2,706 | $113 |
| Bone marrow, smear interpretation | 44 | $2,556 | $54 |
| Microscopic genetic analysis of tumor, manual | 36 | $2,538 | $36 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 50 | $2,332 | $30 |
| Special stained specimen slides to examine tissue, initial procedure | 52 | $2,053 | $30 |
| Pathology cytologic examination of specimen during surgery, each additional site | 35 | $1,918 | $29 |
| Pathology examination of specimen during surgery, first tissue block | 20 | $1,444 | $47 |
| Evaluation of fine needle aspirate with interpretation and report | 19 | $1,309 | $52 |
| Bone marrow, smear interpretation | 30 | $1,175 | $37 |
| Genetic sequencing localization, initial procedure | 29 | $1,125 | $35 |
| Special stained specimen slides to examine tissue including interpretation and report | 43 | $1,064 | $9 |
| Pathology examination of specimen during surgery, first tissue block | 12 | $1,034 | $49 |
| Genetic sequencing localization, each additional procedure | 26 | $1,033 | $28 |
| Evaluation of fine needle aspirate with interpretation and report | 14 | $821 | $51 |
| Genetic sequencing localization, initial procedure | 11 | $745 | $50 |
| Preparation of tissue for examination by removing any calcium present | 70 | $737 | $9 |
| Special stained specimen slides to identify organisms including interpretation and report | 18 | $683 | $21 |
| Special stained specimen slides to examine tissue including interpretation and report | 13 | $573 | $15 |
| Examination of archival tissue for genetic analysis | 30 | $540 | $18 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 24 | $535 | $22 |
| Cell examination of specimen, selective cellular enhancement technique | 11 | $412 | $32 |
| Pathology examination of tissue using a microscope, moderately low complexity | 43 | $361 | $8 |
| Blood smear interpretation by physician with written report | 12 | $227 | $17 |
| Cell examination of specimen, concentration technique | 12 | $209 | $17 |
| Preparation of tissue for examination by removing any calcium present | 14 | $178 | $10 |
2020: 30 services
| Special stained specimen slides to examine tissue, each additional procedure | 103 | $16,634 | $23 |
| Pathology examination of tissue using a microscope, intermediate complexity | 178 | $8,928 | $30 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 58 | $7,951 | $54 |
| Microscopic genetic analysis of tumor, manual | 96 | $6,125 | $35 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 82 | $5,813 | $68 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 24 | $5,661 | $72 |
| Pathology examination of tissue using a microscope, intermediate complexity | 120 | $5,445 | $28 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 68 | $4,722 | $67 |
| Special stained specimen slides to examine tissue, initial procedure | 116 | $4,040 | $29 |
| Microscopic genetic analysis of tumor, manual | 36 | $3,765 | $37 |
| Pathology examination of tissue using a microscope, moderately high complexity | 42 | $3,659 | $67 |
| Special stained specimen slides to examine tissue, each additional procedure | 33 | $3,090 | $24 |
| Bone marrow, smear interpretation | 36 | $2,068 | $56 |
| Genetic sequencing localization, initial procedure | 46 | $1,935 | $37 |
| Bone marrow, smear interpretation | 46 | $1,861 | $40 |
| Special stained specimen slides to examine tissue, initial procedure | 45 | $1,584 | $30 |
| Pathology cytologic examination of specimen during surgery, initial site | 24 | $1,397 | $50 |
| Genetic sequencing localization, each additional procedure | 33 | $1,321 | $29 |
| Special stained specimen slides to examine tissue including interpretation and report | 51 | $1,202 | $10 |
| Cell examination of specimen, selective cellular enhancement technique | 28 | $795 | $22 |
| Pathology examination of specimen during surgery, first tissue block | 12 | $755 | $50 |
| Preparation of tissue for examination by removing any calcium present | 54 | $573 | $10 |
| Genetic sequencing localization, initial procedure | 13 | $571 | $36 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $492 | $10 |
| Genetic sequencing localization, each additional procedure | 12 | $451 | $28 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 12 | $371 | $31 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 11 | $288 | $26 |
| Pathology examination of tissue using a microscope, moderately low complexity | 27 | $246 | $8 |
| Blood smear interpretation by physician with written report | 12 | $237 | $20 |
| Preparation of tissue for examination by removing any calcium present | 19 | $202 | $10 |
2019: 24 services
| Special stained specimen slides to examine tissue, each additional procedure | 62 | $8,877 | $23 |
| Pathology examination of tissue using a microscope, intermediate complexity | 115 | $5,564 | $30 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 67 | $4,790 | $68 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 45 | $3,143 | $68 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 24 | $2,867 | $52 |
| Pathology examination of tissue using a microscope, intermediate complexity | 55 | $2,636 | $31 |
| Special stained specimen slides to examine tissue, each additional procedure | 26 | $2,466 | $23 |
| Special stained specimen slides to examine tissue, initial procedure | 68 | $2,199 | $29 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 12 | $2,085 | $52 |
| Microscopic genetic analysis of tumor, manual | 44 | $1,985 | $34 |
| Pathology examination of tissue using a microscope, moderately high complexity | 20 | $1,774 | $66 |
| Bone marrow, smear interpretation | 26 | $1,520 | $58 |
| Pathology cytologic examination of specimen during surgery, initial site | 19 | $1,189 | $50 |
| Genetic sequencing localization, initial procedure | 29 | $1,178 | $36 |
| Genetic sequencing localization, each additional procedure | 27 | $1,022 | $28 |
| Microscopic genetic analysis of tumor, manual | 17 | $985 | $34 |
| Bone marrow, smear interpretation | 24 | $938 | $39 |
| Special stained specimen slides to examine tissue, initial procedure | 26 | $769 | $28 |
| Cell examination of specimen, selective cellular enhancement technique | 22 | $711 | $22 |
| Special stained specimen slides to examine tissue including interpretation and report | 28 | $622 | $10 |
| Special stained specimen slides to examine tissue including interpretation and report | 20 | $495 | $10 |
| Preparation of tissue for examination by removing any calcium present | 41 | $416 | $10 |
| Blood smear interpretation by physician with written report | 12 | $234 | $19 |
| Preparation of tissue for examination by removing any calcium present | 18 | $189 | $10 |
Medicaid work
$7,097 in 2024
Medicaid paid $7,097 for 147 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 112 | $5,889 |
| TISSUE EXAM BY PATHOLOGIST | 22 | $1,055 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $153 |
| 2024 | 147 | 3 | 28 | $7,097 |
| 2023 | 279 | 5 | 21 | $9,956 |
| 2022 | 201 | 3 | 24 | $4,516 |
| 2021 | 904 | 7 | 54 | $46,241 |
| 2020 | 456 | 5 | 30 | $17,154 |
| 2019 | 45 | 2 | 17 | $1,798 |
See the largest Medicaid services in earlier years
2023
| TISSUE EXAM BY PATHOLOGIST | 107 | $5,476 |
| TISSUE EXAM BY PATHOLOGIST | 40 | $2,750 |
| Blood smear, peripheral, interpretation by physician with written report | 106 | $1,299 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 14 | $380 |
| Level I - Surgical pathology, gross examination only | 12 | $51 |
2022
| TISSUE EXAM BY PATHOLOGIST | 40 | $2,104 |
| Blood smear, peripheral, interpretation by physician with written report | 137 | $1,695 |
| TISSUE EXAM BY PATHOLOGIST | 24 | $717 |
2021
| TISSUE EXAM BY PATHOLOGIST | 316 | $21,472 |
| TISSUE EXAM BY PATHOLOGIST | 43 | $7,539 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 82 | $5,900 |
| Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result | 141 | $4,520 |
| Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervision | 153 | $3,837 |
| Pap test | 156 | $2,588 |
| TISSUE EXAM BY PATHOLOGIST | 13 | $384 |
2020
| TISSUE EXAM BY PATHOLOGIST | 171 | $9,377 |
| Cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation; with screening by automated system and manual rescreening or review, under physician supervision | 96 | $2,551 |
| Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result | 74 | $2,472 |
| Pap test | 101 | $1,899 |
| Immunohistochemistry or immunocytochemistry, per specimen; initial single antibody stain procedure | 14 | $855 |
2019
| TISSUE EXAM BY PATHOLOGIST | 33 | $1,518 |
| Pap test | 12 | $280 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1750725222
- Licence
- WA MD60943137Washington MD.MD.60943137: Expired
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207ZP0102X (207ZP0102X); Student in a training program (390200000X)
- Mailing address
- Po Box 3405, Spokane, WA, 99220
- NPI first listed
- 2013-04-26
- NPI last updated
- 2020-03-23
- NPI record certified
- 2020-03-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Drive, Room Hc435, Stanford, CA, 94305